Oxycinchophen
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Oxycinchophen
- DrugBank Accession Number
- DB13596
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 265.2634
Monoisotopic: 265.073893223 - Chemical Formula
- C16H11NO3
- Synonyms
- Oxycinchophen
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism ADihydroorotate dehydrogenase (quinone), mitochondrial inhibitorPlasmodium falciparum (isolate 3D7) - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- ATC Codes
- M01CA03 — Oxycinchophen
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as phenylquinolines. These are heterocyclic compounds containing a quinoline moiety substituted with a phenyl group.
- Kingdom
- Organic compounds
- Super Class
- Organoheterocyclic compounds
- Class
- Quinolines and derivatives
- Sub Class
- Phenylquinolines
- Direct Parent
- Phenylquinolines
- Alternative Parents
- Quinoline carboxylic acids / Phenylpyridines / Hydroxyquinolines / Pyridinecarboxylic acids / Hydroxypyridines / Benzene and substituted derivatives / Vinylogous acids / Heteroaromatic compounds / Azacyclic compounds / Carboxylic acids show 6 more
- Substituents
- 2-phenylpyridine / Aromatic heteropolycyclic compound / Azacycle / Benzenoid / Carboxylic acid / Carboxylic acid derivative / Heteroaromatic compound / Hydrocarbon derivative / Hydroxypyridine / Hydroxyquinoline show 14 more
- Molecular Framework
- Aromatic heteropolycyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- UK6392GD5W
- CAS number
- 485-89-2
- InChI Key
- XAPRFLSJBSXESP-UHFFFAOYSA-N
- InChI
- InChI=1S/C16H11NO3/c18-15-13(16(19)20)11-8-4-5-9-12(11)17-14(15)10-6-2-1-3-7-10/h1-9,18H,(H,19,20)
- IUPAC Name
- 3-hydroxy-2-phenylquinoline-4-carboxylic acid
- SMILES
- OC(=O)C1=C(O)C(=NC2=CC=CC=C12)C1=CC=CC=C1
References
- General References
- Not Available
- External Links
- Human Metabolome Database
- HMDB0032337
- ChemSpider
- 9822
- BindingDB
- 50201927
- ChEBI
- 135094
- ChEMBL
- CHEMBL219376
- ZINC
- ZINC000000001877
- Wikipedia
- Oxycinchophen
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.0849 mg/mL ALOGPS logP 3.86 ALOGPS logP 3.94 Chemaxon logS -3.5 ALOGPS pKa (Strongest Acidic) 3.36 Chemaxon pKa (Strongest Basic) 1.72 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 70.42 Å2 Chemaxon Rotatable Bond Count 2 Chemaxon Refractivity 73.98 m3·mol-1 Chemaxon Polarizability 27.36 Å3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS splash10-0fy9-0390000000-87a47ad43fbc6524191c Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-014i-0090000000-ab0f0b473ae861a4cfef Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-00di-0090000000-85c93db09bb8c2816bd2 Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-014i-0090000000-c0e83019a7d2cbde5976 Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-00di-0090000000-d8bd690adad8f81e7f38 Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-00xs-0980000000-5cb9b26f9dd11c418666 Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-0ff0-0930000000-57e848fd35a40a371def Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 170.0645294 predictedDarkChem Lite v0.1.0 [M-H]- 169.8220294 predictedDarkChem Lite v0.1.0 [M-H]- 157.37285 predictedDeepCCS 1.0 (2019) [M+H]+ 170.2732294 predictedDarkChem Lite v0.1.0 [M+H]+ 170.4919294 predictedDarkChem Lite v0.1.0 [M+H]+ 159.73088 predictedDeepCCS 1.0 (2019) [M+Na]+ 170.1677294 predictedDarkChem Lite v0.1.0 [M+Na]+ 170.3286294 predictedDarkChem Lite v0.1.0 [M+Na]+ 165.82402 predictedDeepCCS 1.0 (2019)
Targets
Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
- Kind
- Protein
- Organism
- Plasmodium falciparum (isolate 3D7)
- Pharmacological action
- Yes
- Actions
- Inhibitor
- General Function
- Catalyzes the conversion of dihydroorotate to orotate with quinone as electron acceptor.
- Specific Function
- dihydroorotate dehydrogenase (quinone) activity
- Gene Name
- Not Available
- Uniprot ID
- Q08210
- Uniprot Name
- Dihydroorotate dehydrogenase (quinone), mitochondrial
- Molecular Weight
- 65557.87 Da
References
- Zhou Y, Zhang Y, Zhao D, Yu X, Shen X, Zhou Y, Wang S, Qiu Y, Chen Y, Zhu F: TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Res. 2024 Jan 5;52(D1):D1465-D1477. doi: 10.1093/nar/gkad751. [Article]
Drug created at June 23, 2017 20:45 / Updated at August 27, 2024 19:16